A
A

Adidas

Trade Ideas

Traders Sentiment

Technical Summary

Hourly

News

European stocks slip on Evergrande woes, weak German business morale

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) * Friday's declines cut Europe's weekly gains * Germans head to vote on Sunday * Adidas, Puma slide after Nike warning By Sruthi Shankar and Shreyashi Sanyal Sept 24 (Reuters) - European stocks fell on Friday as worries about troubled proper
A
P
G
E
F
U

European stocks slide as Evergrande concerns resurface

(For a Reuters live blog on U.S., UK and European stock markets, click LIVE/ or type LIVE/ in a news window) Sept 24 (Reuters) - European stocks slipped at the open on Friday on lingering worries about troubled property developer China Evergrande, with mining and retail stocks exposed to the Asian country among the biggest decliners. The regionwide
A
P
G
E
F
U

British Business - Sept 8

Sept 8 (Reuters) - The following are the top stories on the business pages of British newspapers. Reuters has not verified these stories and does not vouch for their accuracy. The Times - British gambling group 888 Holdings plc 888.L has won the race to acquire European operations of William Hill Ltd after outbidding Apollo Global Management Inc AP
A
A
B
M
T
P

European stocks log best winning streak since 2006, fourth week of gains

* German DAX at record high * France CAC 40 highest since 2000 * Zooplus surges on take-private deal By Sruthi Shankar and Shreyashi Sanyal Aug 13 (Reuters) - European stocks scaled new highs on Friday and clocked their fourth consecutive week of gains on optimism over a strong earnings season and steady recovery from the pandemic-led economic down
A
I
G
E
F
I
U

New York Times business news - Aug 13

Aug 13 (Reuters) - The following are the top stories on the New York Times business pages. Reuters has not verified these stories and does not vouch for their accuracy. - The U.S. Food and Drug Administration on Thursday granted authorization for third doses of Pfizer-BioNTech's PFE.N 22UAy.DE and Moderna's MRNA.O coronavirus vaccines for people wi
A
P

Conditions

Popular Assets

Disclaimer: The XM Group entities provide execution-only service and access to our Online Trading Facility, permitting a person to view and/or use the content available on or via the website, is not intended to change or expand on this, nor does it change or expand on this. Such access and use are always subject to: (i) Terms and Conditions; (ii) Risk Warnings; and (iii) Full Disclaimer. Such content is therefore provided as no more than general information. Particularly, please be aware that the contents of our Online Trading Facility are neither a solicitation, nor an offer to enter any transactions on the financial markets. Trading on any financial market involves a significant level of risk to your capital.

All material published on our Online Trading Facility is intended for educational/informational purposes only, and does not contain – nor should it be considered as containing – financial, investment tax or trading advice and recommendations; or a record of our trading prices; or an offer of, or solicitation for, a transaction in any financial instruments; or unsolicited financial promotions to you.

Any third-party content, as well as content prepared by XM, such as: opinions, news, research, analyses, prices and other information or links to third-party sites contained on this website are provided on an “as-is” basis, as general market commentary, and do not constitute investment advice. To the extent that any content is construed as investment research, you must note and accept that the content was not intended to and has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such, it would be considered as marketing communication under the relevant laws and regulations. Please ensure that you have read and understood our Notification on Non-Independent Investment. Research and Risk Warning concerning the foregoing information, which can be accessed here.

We are using cookies to give you the best experience on our website. Read more or change your cookie settings.

Risk Warning: Your capital is at risk. Leveraged products may not be suitable for everyone. Please consider our Risk Disclosure.